Company Filing History:
Years Active: 2021
Title: Innovations of Jinyoung Bae in Pain Management
Introduction
Jinyoung Bae is an innovative inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pain management through his research and inventions. His work focuses on developing novel therapeutic approaches to treat pain effectively.
Latest Patents
Jinyoung Bae holds a patent for an invention titled "SCN9A antisense pain killer." This invention provides peptide nucleic acid derivatives that target the 3' splice site of exon 4 in the human SCN9A pre-mRNA. The peptide nucleic acid derivatives potently induce SCN9A mRNA splice variant(s) that lack the SCN9A exon 4 in cells. This innovative approach is useful for safely treating pains or conditions involving Na1.7 activity.
Career Highlights
Jinyoung Bae is currently associated with Olipass Corporation, where he continues to advance his research in pain management. His work has garnered attention for its potential to revolutionize how pain is treated, offering new hope for patients suffering from chronic pain conditions.
Collaborations
Some of Jinyoung Bae's notable coworkers include Shin Chung and Daram Jung. Their collaborative efforts contribute to the innovative environment at Olipass Corporation, fostering advancements in therapeutic solutions.
Conclusion
Jinyoung Bae's contributions to pain management through his innovative patent demonstrate his commitment to improving healthcare solutions. His work exemplifies the potential of scientific research to create effective treatments for pain relief.